Abstract:OBJECTIVE:To study the roles of advanced glycation end products and its receptor on fetal brain injury of gestational diabetes mellitus (GDM) rats. METHODS:Twenty one adult pregnant Wistar rats were administered streptozotocin (STZ) intraperitoneally to induce GDM rats model. The fourteen pregnant rats were divided into two groups according to the fasting glucose on the 3(rd) day of pregnancy:severe GDM group with the fasting glucose > 16.7 mmol/L and mild GDM group with the fasting glucose between 6.7 - 16.7 mmol/L. Another seven pregnant rats were chosen as the severe GDM and intervention with micronutrient group, receiving gavage with micronutrient during the whole pregnancy. Five control rats received the same volume of citric acid buffer. All the pregnant rats were tested fasting glucose from the tail vein and their weight on the pregnant day 3, 13 and 19. Maternal serum levels of AGE were measured by ELISA and RAGE levels in the embryonic brain tissues were tested by immunohistochemistry. RESULTS:(1) There was no statistically significant difference of pre-pregnancy fasting glucose level among all groups (P > 0.05). The fasting glucose levels on the 3(rd) day and the mean fasting glucouse level of pregnancy in the severe GDM group and the severe GDM and intervention with micronutrient group were higher than those of the control group (P < 0.05). And there was no significant difference between the severe GDM group and the severe GDM and intervention with micronutrient group (P > 0.05). (2) The serum AGE levels in the severe GDM group and the mild GDM group were (1037 ± 38) ng/L and (880 ± 34) ng/L respectively, with no significant difference (P > 0.05). The serum AGE levels in the control group and the severe GDM and intervention with micronutrient group were (857 ± 32) ng/L and (988 ± 37) ng/L, and the difference was statistically significant (P < 0.05). The serum AGE levels in the severe GDM and intervention with micronutrient group and in the mild GDM group had no significant difference (P > 0.05). (3) The serum AGE levels in the severe GDM group, mild GDM group and the control group were positively associated with the mean glucose level of pregnancy (r = 0.603, P < 0.05) and the grlucose on the 3(rd) day of pregnancy (r = 0.704, P < 0.05). (4) The fetal brain nerve cell number and morphology in the control group were normal. While in the mild GDM group fetal brain nerve cells decreased, the proliferation and swelling of glial cells were seen. In the severe GDM group and the severe GDM and intervention with micronutrient group, the fetal brain cells furtherly reduced, and large vacuole around the cells, deformation and debris of the cells were seen. Glial scar formation was visible in some fetal brain tissues. There was a few RAGE expression in the control fetal brain tissues. In the mild GDM group and the severe GDM group, RAGE expression increased significantly. And the RAGE expression intensity in the severe GDM and intervention with micronutrient group was between the severe and the mild GDM groups. CONCLUSIONS:(1) Abnormal fetal brain development of GDM rats was associated with the increase of maternal serum AGE and the enhancement of RAGE expression in fetal brain tissues, which suggested that AGE/RAGE pathway may play an important role in the fetal brain injury of GDM rats. (2) Micronutrients can reduce the brain damage of GDM fetuses.

Antenatal Blockade of N-Methyl-d-aspartate Receptors by Memantine Reduces the Susceptibility to Diabetes Induced by a High-Fat Diet in Rats with Intrauterine Growth Restriction†

Excessive Activation of NMDA Receptors Induced Neurodevelopmental Brain Damage and Cognitive Deficits in Rats Exposed to Intrauterine Hypoxia

Effects of Excessive Activation of N-methyl-D-aspartic Acid Receptors in Neonatal Cardiac Mitochondrial Dysfunction Induced by Intrauterine Hypoxia

The Impaired Myocardial Ischemic Tolerance in Adult Offspring of Diabetic Pregnancy is Restored by Maternal Melatonin Treatment

Synergistic Effects of Folic Acid and <i>n</i>-3 Polyunsaturated Fatty Acid in Preventing Neural Tube Defects in Diabetic Mice

Retardation of fetal dendritic development induced by gestational hyperglycemia is associated with brain insulin/IGF-I signals

N-3 Polyunsaturated Fatty Acids Effectively Protect Against Neural Tube Defects in Diabetic Mice Induced by Streptozotocin.

[Roles of Advanced Glycation End Products and Its Receptor on the Fetal Brain Injury in Pregnant Rats with Gestational Diabetes Mellitus].

The Effects of Induced Type I Diabetes on Developmental Regulation of GDNF, NRTN, and NCAM proteins in the Dentate Gyrus of male Rat offspring

Maternal N-Acetyl Cysteine Intake Improved Glucose Tolerance in Obese Mice Offspring

Protection of Male Rat Offspring against Hypertension Programmed by Prenatal Dexamethasone Administration and Postnatal High-Fat Diet with the Nrf2 Activator Dimethyl Fumarate during Pregnancy

Maternal n-7 Unsaturated Fatty Acids Protect the Fetal Brain from Neuronal Degeneration in an Intrauterine Hyperglycemic Animal Model

Therapeutic Effect of Ursolic Acid on Fetal Development in Pregnant Rats with Gestational Diabetes Mellitus Via AGEs-RAGE Signaling Pathway

Prenatal high sucrose intake affected learning and memory of aged rat offspring with abnormal oxidative stress and NMDARs/Wnt signaling in the hippocampus

Intrauterine hyperglycemia-induced inflammatory signalling via the receptor for advanced glycation end products in the cardiac muscle of the infants of diabetic mother rats

N-Methyl-D-aspartate Receptor Excessive Activation Inhibited Fetal Rat Lung DevelopmentIn VivoandIn Vitro

N-Acetyl-l-cysteine ameliorates gestational diabetes mellitus by inhibiting oxidative stress

Maternal High-Fat Diet Reduces Type-2 Neural Stem Cells and Promotes Premature Neuronal Differentiation during Early Postnatal Development

Long-term Effects of Maternal Diabetes on Blood Pressure and Renal Function in Rat Male Offspring.

Gestational Diabetes Mellitus Remodels the Fetal Brain Fatty Acid Profile Through Placenta-Brain Lipid Axis in C57BL/6J Mice

GLP‐1 rescued gestational diabetes mellitus‐induced suppression of fetal thalamus development